1. Home
  2. SLNO vs CRVL Comparison

SLNO vs CRVL Comparison

Compare SLNO & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • CRVL
  • Stock Information
  • Founded
  • SLNO 1999
  • CRVL 1987
  • Country
  • SLNO United States
  • CRVL United States
  • Employees
  • SLNO N/A
  • CRVL N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CRVL Specialty Insurers
  • Sector
  • SLNO Health Care
  • CRVL Finance
  • Exchange
  • SLNO Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • SLNO 3.8B
  • CRVL 4.4B
  • IPO Year
  • SLNO 2014
  • CRVL 1991
  • Fundamental
  • Price
  • SLNO $52.75
  • CRVL $85.82
  • Analyst Decision
  • SLNO Strong Buy
  • CRVL
  • Analyst Count
  • SLNO 10
  • CRVL 0
  • Target Price
  • SLNO $112.50
  • CRVL N/A
  • AVG Volume (30 Days)
  • SLNO 1.9M
  • CRVL 152.3K
  • Earning Date
  • SLNO 11-05-2025
  • CRVL 11-04-2025
  • Dividend Yield
  • SLNO N/A
  • CRVL N/A
  • EPS Growth
  • SLNO N/A
  • CRVL 27.81
  • EPS
  • SLNO N/A
  • CRVL 1.93
  • Revenue
  • SLNO $32,656,999.00
  • CRVL $918,578,000.00
  • Revenue This Year
  • SLNO N/A
  • CRVL N/A
  • Revenue Next Year
  • SLNO $175.39
  • CRVL N/A
  • P/E Ratio
  • SLNO N/A
  • CRVL $44.38
  • Revenue Growth
  • SLNO N/A
  • CRVL 12.46
  • 52 Week Low
  • SLNO $41.50
  • CRVL $84.68
  • 52 Week High
  • SLNO $90.32
  • CRVL $128.61
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 24.40
  • CRVL 43.01
  • Support Level
  • SLNO $50.63
  • CRVL $84.88
  • Resistance Level
  • SLNO $72.99
  • CRVL $93.45
  • Average True Range (ATR)
  • SLNO 4.32
  • CRVL 2.76
  • MACD
  • SLNO -1.06
  • CRVL 0.02
  • Stochastic Oscillator
  • SLNO 9.34
  • CRVL 15.45

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: